Page last updated: 2024-11-03
probenecid and Myositis
probenecid has been researched along with Myositis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Myositis: Inflammation of a muscle or muscle tissue.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Iuliano, P | 1 |
Lama, G | 1 |
Reviews
1 review available for probenecid and Myositis
Article | Year |
---|---|
[Dermatomyositis and polymyositis].
Topics: Adrenal Cortex Hormones; Dermatomyositis; Edetic Acid; Etidronic Acid; Heart Diseases; Humans; Immun | 1982 |